Articlenpj biomedical innovations2025
Wearable battery-free chip-less patch for bioimpedance measurement of cutaneous lesions.
Article in npj biomedical innovations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Wearable Electronics for Precision Diagnosis Through Advanced Manufacturing and Integration.Nano-micro letters · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Melanoma is an invasive type of skin cancer that may metastasize and cause death. Early identification and timely management of melanoma significantly increase the chance of successful treatment and reduce the mortality rate. Visual inspection of pigmented lesions is not objective, often necessitating additional diagnostic procedures such as dermoscopy, reflectance confocal microscopy and biopsy. Here, we developed a wireless, battery-free, chip-less patch that non-invasively measures bio-impedance of lesions and suspicious parts of skin to melanoma as a complementary, nonvisual, wearable device. The patch, in conjunction with personal electronics, can detect abnormal bioimpedances that are associated with the risk of melanoma and alert the need for medical consultation in the early stage of development. Our analytical and experimental results as well as a pilot human subject study showed that the wearable patch identified the difference in bioimpedance of pigmented lesions and healthy tissues on skin for early assessment of lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.